Omaveloxolone (Skyclarys®). HTA ID: 24033

Assessment Status Full HTA submission received from Applicant
HTA ID 24033
Drug Omaveloxolone
Brand Skyclarys®
Indication For the treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older
Assessment Process
Rapid review commissioned 02/08/2024
Rapid review completed 29/08/2024
Rapid review outcome A full HTA is recommended to assess the clinical effectiveness and cost effectiveness of omaveloxolone compared with the current standard of care.
Full pharmacoeconomic assessment commissioned by HSE 25/09/2024
Pre-submission consultation with Applicant 04/02/2025
Full submission received from Applicant 02/07/2025